Hepatitis E virus (HEV) is a positive-strand RNA virus and a major causative agent of acute sporadic and epidemic hepatitis. HEV replication protein is encoded by ORF1 and contains the predicted domains of methyltransferase (MT), protease, macro domain, helicase (HEL) and polymerase (POL). In this study, the full-length protein pORF1 (1693 aa) and six truncated variants were expressed by in vitro translation and in human HeLa and hepatic Huh-7 cells by using several vector systems. The proteins were visualized by three specific antisera directed against the MT, HEL and POL domains. In vitro translation of full-length pORF1 yielded smaller quantities of two fragments. However, these fragments were not observed after pORF1 expression and pulse-chase studies in human cells, and their production was not dependent on the predicted protease domain in pORF1. The weight of evidence supports the proposition that pORF1 is not subjected to specific proteolytic processing, which is unusual among animal positive-strand RNA viruses but common for plant viruses. pORF1 was membrane associated in cells and localized to a perinuclear region, where it partially overlapped with localization of the endoplasmic reticulum (ER) marker BAP31 and was closely interspersed with staining of the ERGolgi intermediate compartment marker protein ERGIC-53. Co-localization with BAP31 was enhanced by treatment with brefeldin A. Therefore, HEV may utilize modified early secretory pathway membranes for replication.
INTRODUCTION
Hepatitis E virus (HEV) has been classified in its own genus, Hepevirus, in the family Hepeviridae (Purcell & Emerson, 2008) . HEV is a major causative agent of acute sporadic and epidemic hepatitis in many developing countries. The virus is commonly transmitted via the faecal-oral route, usually through contaminated drinking water. There is increasing evidence that HEV is also common in western countries in swine and may exist in other animals. Many cases of HEV are not associated with travel to endemic areas but are acquired locally from animals or other sources. HEV grows very poorly in cultured cells, and similarly only a low level of RNA replication has been obtained when genomic transcripts or transcripts of replicons have been transfected to cells (Emerson et al., 2004 (Emerson et al., , 2010 Panda et al., 2000; Thakral et al., 2005) . However, recently, some improved cell-culture systems have been reported (Okamoto, 2011; Yamada et al., 2009b) .
HEV virions are small (27-34 nm in diameter), nonenveloped and contain a 7.2 kb positive-strand RNA genome, which has 59 cap and 39 poly(A) structures (Ahmad et al., 2011) . The HEV genome consists of three partially overlapping ORFs and short non-coding regions. ORF1 is located at the 59 end of the genome, and encodes the RNA replication proteins of the virus. ORF2 encodes the viral capsid protein of 660 aa, truncated forms of which can self-assemble into virus-like particles (Mori & Matsuura, 2011) . ORF3 overlaps for almost all of its length with the beginning of the capsid ORF2 in a different reading frame. ORF2 and -3 are translated from a bicistronic subgenomic mRNA of 2.2 kb (Graff et al., 2006) . ORF3 encodes a phosphoprotein of 114 aa, which is not required for RNA replication in cell culture but is essential for animal infection, and may be important for virus release from infected cells (Emerson et al., 2010; Yamada et al., 2009a) .
ORF1 encodes the replication protein(s) of HEV, which contain several predicted functional domains (Fig. 1a ) (Ahmad et al., 2011) . Sequence relationships of the domains 3These authors contributed equally to this work. 4Present address: Minerva Foundation Institute for Medical Research, Helsinki, Finland. place HEV firmly in the alphavirus-like superfamily of positive-sense RNA viruses, with rubella virus as the most closely related animal virus (Koonin et al., 1992) . The Nterminal part of pORF1 functions as a virus-specific guanine 7-methyltransferase (MT) and guanylyltransferase, which act in viral RNA capping (Magden et al., 2001) . This multifunctional enzyme catalyses cap formation via a distinct pathway typical for the alphavirus superfamily: the capping guanosine residue is first methylated and only then forms a covalent 7-methyl-GMP-enzyme intermediate from which it is transferred to the 59 end of the RNA (Ahola & Kääriäinen, 1995) . Following the capping enzyme, pORF1 contains an area of very weak sequence similarity with certain viral papain-like cysteine proteases (Koonin et al., 1992) , but the existence of a protease activity has remained uncertain (see Discussion). In the middle of the 1693 aa pORF1, approximately between residues 712 and 775, there is an area rich in proline residues and without predicted secondary structure, which might act as a flexible hinge within the protein. This is followed by a domain initially designated the X domain but more recently called the macro domain, which can bind ADP-ribose and its polymeric form, poly(ADP-ribose) (Neuvonen & Ahola, 2009 ). The predicted helicase (HEL) domain of HEV contains the full complement of conserved helicase motifs and has been demonstrated to carry out NTPase and RNA strandseparation functions (Karpe & Lole, 2010a) , as well as RNA triphosphatase activity (Karpe & Lole, 2010b) . There is also tentative evidence that the most C-terminal domain of pORF1 has RNA-dependent RNA polymerase (POL) activity (Agrawal et al., 2001 ).
Here, we expressed the HEV replication protein pORF1 and its truncated derivatives in vitro, in HeLa cells and in Huh-7 cells. We studied their processing, localization and membrane association using specific antibodies directed against different domains of the protein. Although some fragments of pORF1 were observed in vitro, we obtained no evidence for specific processing of the HEV replication protein in human cells in pulse-chase studies. pORF1 was found in perinuclear membranes closely associated with the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) marker ERGIC-53. Partial overlap with the ER marker BAP31 was further increased by treatment with brefeldin A (BFA).
RESULTS

Expression and processing of HEV replicase proteins in vitro
To study HEV pORF1, we first generated polyclonal rabbit antisera directed against three different domains of the protein, MT, X-HEL and POL (Fig. 1a) . As well as the fulllength pORF1, six truncated variants were made by PCR (Fig. S1a , available in JGV Online). In vitro translation in each case yielded a protein product close to the expected molecular mass (Fig. S1b) . Immunoprecipitation with the antisera was used to verify the identities of the proteins produced ( Fig. S1c-e) . pORF1 was precipitated by all the sera, and for the other constructs the results were also as expected. In several cases, smaller and fainter radioactively labelled products were observed after in vitro translation (Fig. S1b) , which could be due to proteolytic processing, or aberrant translation initiation and/or termination.
To study the fragments derived from pORF1 translation more carefully, the protein was first translated for 90 min, cycloheximide was then added and the incubation was continued at 30 u C for increasing lengths of time, for up to 20 h (Fig. 1b, lanes 1-4) . pORF1 was also translated in the presence of Zn 2+ , which has been shown to be essential for the processing of the distantly related rubella virus replicase protein (Fig. 1b, lane 5) (Liu et al., 1998) . As a control for a well-studied polyprotein processing reaction, we translated in parallel for 90 min the polyprotein P123 of Semliki Forest virus (SFV) (Vasiljeva et al., 2003) , which yielded hardly any full-length protein but gave predominantly the mature products nsP1-3 and the processing intermediate P12 (Fig. 1b, lane 6 ). All translation reactions of pORF1 yielded smaller quantities of two well-defined products of 130 kDa and~57 kDa, whose combined molecular mass equalled the full-length protein. They were visible by 90 min, their production was not influenced by Zn 2+ and their amount increased slowly with longer incubations (Fig. 1b, lanes 1-5) . Immunoprecipitation identified the larger fragment as N-terminal, as it was precipitated by the anti-MT and anti-X-HEL antisera, and the smaller fragment as C-terminal, as it was precipitated only by the anti-POL antiserum (Fig. S1c-e, lane 2) . Notably, translation of X-HEL-POL yielded a C-terminal product of exactly the same molecular mass as pORF1 (Fig. S1b , e, lane 6), strongly suggesting that this fragment was generated by a proteolytic activity present in the translation mixture, rather than a putative protease activity in the Nterminal part of pORF1.
Expression and processing of HEV replicase proteins in cultured cells
In order to study HEV pORF1 in a more natural system, we expressed the same constructs in two human cell lines, HeLa and the hepatoma cell line Huh-7, by infecting the cells with modified recombinant vaccinia virus Ankara (MVA) expressing T7 polymerase followed by Lipofectamine-mediated transfection. To detect possible processing of pORF1, the cells were labelled with radioactive methionine for 1 h and chased with cold methionine for increasing periods of time. After the pulse, pORF1 was easily detected after immunoprecipitation with all three antisera (Fig. 1c-e, lane 1) . It appeared to be degraded slowly during the chase of 4 h (Fig. 1c -e, lane 2) or 16 h (Fig. 1c-e, lane 3) , but significant amounts remained intact, even at the later time point. The experiment was also carried out with long overnight labelling without a chase (Fig. 1c-e, lane 4) . Transfection of the empty vector followed by labelling and immunoprecipitation with the antisera yielded some faint non-specific low-molecular-mass products (Fig. 1f) , which were also present in pORF1-expressing cells (Fig. 1c-e) . Processing products derived from pORF1 were not readily detectable. The most consistently seen smaller band was~120 kDa and appeared to be an N-terminal fragment, as it was detected by the anti-MT and anti-X-HEL antibodies (Fig. 1c, d, lane 2) . A corresponding C-terminal fragment could not be identified. Significantly, there were no stable products whose amounts showed a corresponding increase when pORF1 decreased during the chase. Processing experiments were also carried out in HeLa cells with the MVA expression system, and in Huh-7 cells with the SFV expression system, with similar results (data not shown).
Localization and membrane association of HEV replicase proteins
To study the putative membrane association of HEV replication proteins, HeLa cells expressing pORF1 were first subjected to crude cell-fractionation procedures. The majority of pORF1 was pelleted with membranes sedimenting at 15 000 g (Fig. S2a) . In addition, .50 % of pORF1 also remained associated with membranes in a flotation experiment (Fig. S2b ), indicating that pelleting was not due to the formation of large protein aggregates. Anti-MT Anti -X-HEL Anti-POL Visualization of pORF1 by indirect immunofluorescence microscopy always showed a prominent concentration of the protein in a perinuclear region of the cell (Fig. S2c , panels i and ii; see also below). In contrast, expression of the C-terminal fragments derived from pORF1, X-HEL, X-HEL-POL and POL revealed diffuse staining throughout the cytoplasm (Fig. S2c , panels iv, v and vi), suggesting that these fragments do not target pORF1 to the perinuclear area. MT496, a construct consisting of aa 1-496 of pORF1 (Fig. S2a) , was found in dot-like concentrations in various parts of the cytoplasm, in a pattern not resembling the fulllength protein (Fig. S2c, panel iii) . In a control experiment, it was verified that pORF1 expressed with MVA did not associate non-specifically with MVA-induced or modified membrane structures. For this purpose, HeLa cells expressing pORF1 were fixed 5 h after transfection and the sample was stained with an antibody against the MVA membrane component of immature virions and induced membranes, p16 (Sancho et al., 2002) . As seen in Fig.  S2 (d), HEV pORF1 localization did not overlap with the A14L gene product p16.
To examine the nature of the perinuclear region containing pORF1, HeLa cells were co-stained with markers for various cytoplasmic membrane compartments. Staining with the early Golgi compartment marker GM130 showed a nicely defined perinuclear organelle (Fig. 2a) . However, pORF1 staining did not co-localize with that of GM130, and was always found in a distinct and neighbouring perinuclear area. The lysosomal and late endosomal marker Lamp-2 similarly showed predominant perinuclear localization, which again did not overlap with the area of pORF1 staining (Fig. 2b) . Staining with the ER membrane protein BAP31 (Määttä et al., 2000) showed a reticulate staining throughout the cell (Fig. 2c) . pORF1 seemed to be concentrated in certain regions of BAP31-positive ER membranes (Fig. 2c) , but the co-localization was only partial in these distinct areas (see below). Interestingly, pORF1 followed closely the localization of the intermediate compartment between the ER and Golgi as visualized by ERGIC-53 staining (Fig. 2d) . From the two-dimensional images, it appeared that there was a certain degree of colocalization between ERGIC-53 and pORF1. However, careful analysis of individual confocal microscopy slices, and visualization of three-dimensional reconstructions of the double staining pattern from different angles, showed that the two stains were often localized in very close proximity but did not overlap (Fig. 2e shows the same cell pair as in Fig. 2d) . Thus, these signals were interspersed with each other, and could represent different subdomains of the same subcellular compartment.
In parallel with HeLa cells, we also investigated the localization of pORF1 in Huh7 cells, as they may be more representative of cells permissive to HEV replication. pORF1 was expressed with the MVA/T7 system as described above and pORF1 was visualized with anti-MT antibody. As ER and ERGIC markers gave the most interesting results in HeLa cells, we wanted to investigate further the possible interconnection of pORF1 with early secretory pathway membranes. Similar to previous observations, in Huh-7 cells pORF1 localized in close proximity to ERGIC-53-positive membranes (Fig. 3a) and partially overlapped some areas of ER membranes stained with BAP31 (Fig. 3c) . BFA was added to the cells 1 h before fixation to manipulate the integrity of ERGIC and Golgi membranes and the transport between ER and Golgi. BFA treatment triggers the redistribution of Golgi proteins to the ER; however, ERGIC-53 remains separate, as the intermediate compartment is maintained but partially relocalizes (Klausner et al., 1992; Saraste & Svensson, 1991) . As seen in Fig. 3(b) , ERGIC-53 staining was scattered in the cytoplasm after BFA treatment, whereas pORF1 remained in the perinuclear region resembling the localization without BFA treatment. Interestingly, the degree of co-localization of pORF1 with BAP31-positive ER membranes after BFA treatment was increased (Fig. 3d,  e) . Three-dimensional rendering was used to visualize the co-localization between pORF1 and BAP31 ( Fig. 3e ) and Pearson's coefficient was calculated to compare the increase in co-localization that changed from 0.27±0.07 (without BFA) to 0.42±0.1 (with BFA). We also expressed HEV pORF1 in Huh7 cells by means independent of MVA by cloning it under the human cytomegalovirus (CMV) promoter. Similar to the MVA/T7 system, pORF1 localized in the perinuclear region closely neighbouring the ERGIC-53-positive intermediate compartment and connected with certain areas of BAP31-positive ER regions (not shown).
DISCUSSION Proteolytic processing of pORF1
Alignment with the sequence of the rubella virus protease initially predicted that HEV pORF1 might include a domain related to papain-like cysteine proteases, but the statistical significance was quite weak compared with the other functional domains predicted in ORF1 (Koonin et al., 1992) . Five previous studies have addressed the possible proteolytic processing of pORF1 (Ansari et al., 2000; Panda et al., 2000; Ropp et al., 2000; Sehgal et al., 2006; Suppiah et al., 2011) . In these investigations, no significant processing of pORF1 was found after in vitro translation, even with long incubation times. In the experiments reported here, two distinct fragments, an N-terminal 130 kDa and a C-terminal 57 kDa protein, were detected after in vitro translation of pORF1 (Fig. 1b) . However, translation of X-HEL-POL, which does not contain the predicted HEV protease domain, also yielded the 57 kDa product, indicating that it was not produced as a result of that putative activity. It remains possible that co-factors required by the HEV protease are not present in vitro. Therefore, we next studied the processing of pORF1 in human Huh-7 cells, one of the most permissive cell lines for HEV replication (Emerson et al., 2004) . pORF1 was radioactively labelled and its putative processing products were detected with specific antisera, which represent new tools for processing studies (Fig. S1 ). We employed a short pulse labelling time of 1 h and long chase periods of up to 16 h. Chase procedures have not been used in any previous studies of HEV pORF1 processing. However, even under these conditions, no significant processing of pORF1 was detected. In a previous study using transfection of full-length viral RNA, Panda et al. (2000) reported antibody detection of minor quantities of small products, which appeared to be too small to represent functional proteins. Ropp et al. (2000) reported N-terminal 78 kDa and C-terminal 107 kDa proteins derived from pORF1 after long labelling periods in human cells. However, when the putative catalytic cysteine of HEV protease was mutated, cleavage was not abolished. The molecular masses indicated that this cleavage would take place within the proline-rich hinge region. Recent reanalysis of the results suggests that the cleavage is an artefact seen in some systems and with only some HEV sequences (Suppiah et al., 2011) . Therefore, the results of Suppiah et al. (2011) also support the conclusion that pORF1 is not processed, which is further bolstered by their observation that the putative active-site histidine of HEV protease is not conserved in many HEV genotypes. Sehgal et al. (2006) detected multiple fragments after baculovirus-mediated overexpression of pORF1 in insect cells at late time points, but the involvement of a viral protease in the cleavages was not authenticated experimentally.
We argue that there is no convincing evidence supporting specific processing of the HEV replication protein pORF1. Human and preferentially hepatic cell lines represent the best model to study this question with protein expression methods. Even the newest HEV culture systems require incubation times varying from several days to 2 weeks to obtain reasonable titres, indicating a slow rate of RNA replication. ORF2 and ORF3 proteins have been detected by antibodies (Okamoto, 2011) , but the ORF1 replicase may be present in much smaller quantities. It remains to be seen whether these or still more advanced HEV culture systems would be useful to study pORF1. Although the vast majority of animal positive-sense RNA viruses encode a protease in their replicase polyproteins, there are many plant viruses within the alphavirus-like superfamily, distantly related to HEV, which only produce one unprocessed protein of a size comparable to or even larger than HEV pORF1 and containing similar functional domains (van der Heijden & Bol, 2002) . This suggests that all the replicase functions of RNA capping, helicase and polymerase could also be provided by one large protein in the case of HEV. Interestingly, deubiquitination activity has been demonstrated recently for the initially predicted protease domain of HEV (Karpe & Lole, 2011) . Structural studies of this domain might indicate whether it represents an ancestral viral protease that has lost its activity but gained/retained a deubiquitination function.
Localization of pORF1
The replication complexes of all known eukaryotic positive-strand RNA viruses are associated with cellular membranes (Salonen et al., 2005) . In the alphavirus superfamily, both alphaviruses and rubella virus replicate on the surface of endosomes and lysosomes (Kujala et al., 1999; Salonen et al., 2003) , whereas the replication of several plant viruses takes place on ER membranes. The virus-encoded replicase proteins are responsible for directing the replication complexes to their destination membranes. Biochemical analysis by simple membrane fractionation suggested that pORF1 associates with cellular membranes, and immunofluorescence staining localized pORF1 to a distinct perinuclear region. However, this region did not correspond to the Golgi or the lysosomal compartment. Of the markers examined, pORF1 localized most closely with the ERGIC protein ERGIC-53 (Fig. 2) . However, although the ERGIC-53-and pORF1-positive regions were found immediately adjacent to each other, they did not co-localize. BFA blocks transport from the ER to the Golgi; however, the retrograde transport from the Golgi seems to be enhanced, and the early Golgi collapses to the ER (Klausner et al., 1992) . At the same time, ERGIC maintains a separate identity, and rapidly recycling proteins accumulate in ERGIC upon BFA treatment (Hauri et al., 2000) . pORF1 did not follow the distribution of ERGIC-53 in BFA-treated cells, suggesting that pORF1 does not behave like rapidly recycling proteins. In untreated cells, pORF1 showed some co-localization in specific regions stained with an integral ER protein, BAP31. In BFA-treated cells pORF1 co-localization with BAP31-positive ER membranes was increased, supporting the proposal that pORF1 is associated with early secretory pathway membranes (Fig. 3) . Therefore, pORF1-positive membrane domains might represent an altered subcompartment of the early secretory pathway. Modified early secretory pathway membranes have been demonstrated to be induced and utilized by several groups of positive-strand RNA viruses, including picornaviruses and coronaviruses (Hsu et al., 2010; Reggiori et al., 2010) .
The replicase proteins of positive-strand RNA viruses generally determine the localization of replication sites (Salonen et al., 2005) . For instance, when alphavirus replicase is expressed as a full-length polyprotein, it localizes correctly to the inner surface of the plasma membrane and the outer surface of endo/lysosomes (Salonen et al., 2003) , even though the specific membrane invaginations or spherules only arise when the viral RNA is also provided (Spuul et al., 2011) . Therefore, it is reasonable to suggest that full-length pORF1 also could localize in its native manner, even in the absence of viral RNA. pORF1 possesses some hydrophobic properties and the N-terminal regions of the protein are also membrane associated when expressed in the baculovirus system (Magden et al., 2001) . Interestingly, localization of the short pORF1-derived domains MT496, X-HEL and POL did not coincide with the localization of pORF1, indicating that the latter possesses a combination of targeting determinants not included in the shorter fragments. Further studies are required to identify the targeting determinants, and to characterize the process by which pORF1 attaches to and influences cellular membranes.
METHODS
Cells and viruses. HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10 % FCS, 2 mM L-glutamine, 100 U penicillin and 100 mg streptomycin ml 21 . Human hepatoma Huh-7 cells, kindly provided by Ralf Bartenschlager (University of Heidelberg, Germany), were grown in the same medium further supplemented with non-essential amino acids. MVA encoding T7 RNA polymerase (Wyatt et al., 1995) , provided by Bernard Moss (NIH, Bethesda, MD, USA), was propagated in baby hamster kidney (BHK) cells. Recombinant SFV virus replicon particles (VRPs) were produced by transfecting in vitro-transcribed RNAs into BHK cells as described previously (Chikkanna-Gowda et al., 2005) . The collected VRPs were then used to infect HeLa cells at an m.o.i. of 0.5 particles per cell.
Plasmid constructs and in vitro translation. Plasmid pET30aORF1, containing the full-length ORF1 of HEV (Myanmar strain; Magden et al., 2001) , was used as a starting point. ORF1 and its fragments were amplified by PCR with the primers listed in Table S1 . The PCR products were cloned into HindIII/EcoRI-digested vector pSP73 (Promega) under the control of the T7 promoter and verified by DNA sequencing. In vitro translation of HEV pORF1 and its derivatives was performed using a TNT T7 Quick Coupled Transcription/Translation System (Promega) according to the manufacturer's instructions. The reactions were performed in 25 ml with 1 mg DNA and incubated at 30 uC for 90 min unless specified otherwise.
For localization studies, MT496 was cloned into the pSFV10-E vector (Chikkanna-Gowda et al., 2005) , from which its expression is driven by the SFV subgenomic RNA promoter. The polylinker of the vector was first modified by inserting annealed oligonucleotides polylinker_s and polylinker_as (Table S1) into SpeI/XhoI-digested vector. The linearization site of the vector was also changed to PmeI by inserting the annealed oligonucleotide pair PmeI_s and PmeI_as (Table S1) into NruI-treated vector. The resulting plasmid was then digested with PmeI and religated. HEV MT496 was inserted into BamHI/XhoIdigested modified pSFV10-E vector as a BglII-XhoI fragment derived from the corresponding pSP73 series vector. To clone HEV ORF1 under the control of the CMV promoter, the ORF1 sequence was transferred from pSP73 plasmid as a HindIII-EcoRI fragment to pcDNA4/TO (Invitrogen).
Transfection, radioactive labelling and cell fractionation.
Fragments of HEV ORF1 were expressed using MVA encoding the T7 RNA polymerase. HeLa or Huh-7 cells were infected with MVA at an m.o.i. of 20 for 1 h, followed by transfection and incubation for 6-8 h at 37 uC. Lipofectamine 2000 transfection reagent (Invitrogen) was used according to the manufacturer's instructions. For labelling with [
35 S]methionine, cells on 6 cm dishes were incubated in methionine-free minimum essential medium (ICN Biomedicals) for 30 min and pulse labelled with 150 mCi [
S]methionine (1000 Ci mmol
21 ; GE Healthcare) in methionine-free medium starting at 7 h post-transfection for 1 h or for longer periods as specified for individual experiments. The cells were chased with a 20-fold excess of unlabelled methionine for 1, 4 or 16 h at 37 uC. Cells were harvested, washed with PBS, swollen in five pellet volumes of 10 mM Tris/HCl (pH 8.0) and 10 mM NaCl, supplemented with Protease Inhibitor Cocktail (Roche) and disrupted in a Dounce homogenizer with 40 strokes. Post-nuclear supernatant was prepared by removing the nuclei and intact cells by centrifugation at 500 g for 10 min. For some experiments, the post-nuclear supernatant was further centrifuged at 15 000 g for 20 min to obtain membrane (P15) and supernatant (S15) fractions. Membrane flotation was carried out as described previously (Ahola et al., 1999) , using post-nuclear supernatant as the starting material.
Immunological techniques. The preparation of immune serum against the HEV MT domain (aa 1-464) has been described previously (Magden et al., 2001) . For preparation of rabbit antisera against the HEV helicase (aa 779-1209) and polymerase (aa 1179-1693) domains, these fragments were cloned into a pET21a vector (Novagen) and expressed in Escherichia coli strain BL21. Cells were grown at 37 uC until the optical density at 595 nm was between 0.6 and 0.8. Thereafter, the cultures were transferred to 15 uC, and protein expression was induced overnight with 100 mM IPTG for helicase and 500 mM for polymerase. After cell breakage with a French press and centrifugation at 15 000 g, the inclusion body pellet was washed with 20 mM Tris/HCl (pH 7.5), 10 mM EDTA, 1 % Triton X-100, 500 mM NaCl, 2 M urea, and then with PBS. Inclusion bodies were resuspended in PBS containing 0.5 % SDS. The immunization of rabbits was carried out as described previously (Kujala et al., 1999) .
For immunoprecipitation, samples were denatured by boiling in the presence of 1 % SDS and then incubated overnight in the presence of antibody in RIPA buffer (pH 8.0) at 6 uC. Protein A-Sepharose (GE Healthcare) was then added for 1 h. The beads were washed with RIPA buffer containing 0.1 % SDS, and the immunoprecipitates were analysed by SDS-PAGE (10 % acrylamide). For immunoblotting, proteins were first separated by SDS-PAGE and subsequently electrotransferred to a nitrocellulose membrane. Filters were blocked with 5 % milk powder in PBS supplemented with 0.1 % Tween 20 and probed with specific antibody in the same buffer, followed by secondary antibody (HRP-conjugated swine anti-rabbit; Dako). The proteins were visualized using an enhanced chemiluminescence detection system (GE Healthcare).
Immunofluorescence microscopy. Indirect immunofluorescence microscopy of transfected cells was carried out essentially as described previously (Salonen et al., 2003) . Briefly, cells infected with MVA and then plasmid transfected were fixed at 6 h post-transfection, cells infected with SFV VRPs were fixed at 5 h post-infection and cells transfected with plasmids containing the CMV promoter were fixed at 20 h post-transfection, all with 4 % paraformaldehyde in PBS. Cells were then permeabilized and stained with specific anti-HEV antibodies, followed by treatment with species-specific secondary antibodies conjugated to either Alexa Fluor 568 or Alexa Fluor 488 (Molecular Probes). Antibodies against organelle-specific markers were used for characterization of the distribution of HEV proteins: Golgi matrix protein GM130 (a gift from Eija Jokitalo, Institute of Biotechnology, Helsinki, Finland), human lysosome-associated membrane glycoprotein (Lamp-2; Abcam), integral ER membrane protein BAP31 (a gift from Esa Kuismanen, Division of Biochemistry, University of Helsinki, Helsinki, Finland) and ER-Golgi intermediate compartment protein ERGIC-53 (Alexis Biochemicals). Antibody against MVA membrane protein p16 (product of gene A14L) was a gift from Jacomine Krijnse-Locker (EMBL Heidelberg, Germany). Treatment with 10 mg BFA (Sigma-Aldrich) ml 21 was performed for 1 h before fixing the cells.
The samples were analysed by Leica TCS SP2 confocal scanning microscopy using an HCX PL APO 636/1.4-0.6 oil objective. Further analysis was carried out by ImageJ (NIH, Bethesda, MD, USA), Pearson's coefficient for co-localization was calculated using the JACoP plugin (Bolte & Cordelières, 2006) , and Imaris (Bitplane) was used for three-dimensional rendering and visualization of colocalization.
